| RS1302178938 |
FLT4
|
Health Risk |
Likely pathogenic |
— |
| RS1302190999 |
HMGCL
|
Health Risk |
Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS1302200961 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1302206828 |
EPHB4
|
Health Risk |
Likely pathogenic |
EPHB4-related disorder, EPHB4-related disorder |
| RS1302209410 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, CDKN1C-related disorder |
| RS1302209849 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1302210262 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS1302210667 |
GM2A
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, variant AB |
| RS1302216206 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1302236491 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1302248679 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1302254196 |
ASXL3
|
Health Risk |
Conflicting classifications of pathogenicity |
ASXL3-related disorder, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1302255267 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1302265167 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS1302294029 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1302313826 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1302317350 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS1302326945 |
PPT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1302332659 |
GNAI3;GNAT2;MIR197
|
Health Risk |
Likely pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS1302336455 |
EXT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital exostosis, Ovarian cancer |
| RS1302337975 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1302361762 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1302362911 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1302369946 |
MSH6
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1302373559 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1302387853 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1302398047 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS1302409621 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1302414683 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS1302427305 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 |
| RS1302428933 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1302430730 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1302470051 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 7, GUSB-related disorder |
| RS1302471394 |
SMPD4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, arthrogryposis |
| RS1302487476 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1302506624 |
ITGB3
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1302509857 |
DNAAF4
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 25, Primary ciliary dyskinesia 25 |
| RS1302543317 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS1302547655 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1302552127 |
ERCC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Trichothiodystrophy 2, photosensitive |
| RS1302558061 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1302587036 |
TFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 3, Hereditary hemochromatosis |
| RS1302611253 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1302626569 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1302642659 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Inborn genetic diseases |
| RS1302660801 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1302692296 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS1302694358 |
DDX3X
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1302701490 |
FGA
|
Health Risk |
Likely pathogenic |
Familial visceral amyloidosis, Ostertag type |
| RS1302722012 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1302726543 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS1302735956 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS1302739538 |
GJB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Nonsyndromic genetic hearing loss |
| RS1302747902 |
GJC2
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS1302751005 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1302753011 |
IFT80
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 2, Asphyxiating thoracic dystrophy 2 |
| RS1302764635 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS13027659 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Atypical hemolytic-uremic syndrome |
| RS1302770627 |
ABCA7
|
Health Risk |
Likely pathogenic |
ABCA7-related disorder, ABCA7-related disorder |
| RS1302770820 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS1302782570 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS1302783957 |
COLQ
|
Health Risk |
Pathogenic |
— |
| RS1302797003 |
CRBN
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 2 |
| RS1302809734 |
PROM1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1302810798 |
SQSTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, Paget disease of bone 2 |
| RS1302814429 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant nonsyndromic hearing loss 17 |
| RS1302832406 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1302836963 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral palsy, spastic quadriplegic |
| RS1302840036 |
MED17
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly, Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly |
| RS1302842400 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1302865780 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 9, Hypertrophic cardiomyopathy 9 |
| RS1302879683 |
BBS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 4 |
| RS1302894198 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1302907379 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1302913513 |
ARSG
|
Health Risk |
Likely pathogenic |
Usher syndrome, type 4 |
| RS1302922191 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1302923931 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1302928728 |
CYP24A1
|
Health Risk |
Likely pathogenic |
— |
| RS1302929012 |
DGAT1
|
Health Risk |
Likely pathogenic |
— |
| RS1302931500 |
NLRP12
|
Health Risk |
Pathogenic |
Familial cold autoinflammatory syndrome 2, Familial cold autoinflammatory syndrome 2 |
| RS1302949776 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1302961946 |
PGM1
|
Health Risk |
Likely pathogenic |
— |
| RS1303000161 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS1303000329 |
DLC1
|
Health Risk |
risk factor |
Neural tube defect, Neural tube defect |
| RS1303017241 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1303026707 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1303026901 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1303032996 |
DMXL2
|
Health Risk |
Pathogenic |
— |
| RS1303033636 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS1303038263 |
CFI
|
Health Risk |
Likely pathogenic/Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1303044966 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS1303053833 |
POU3F3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1303057809 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS1303065649 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS1303074743 |
PRKCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 14, Spinocerebellar ataxia type 14 |
| RS1303076207 |
AQP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Diabetes insipidus, nephrogenic |
| RS1303080207 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1303092705 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic right ventricular cardiomyopathy |
| RS1303102528 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1303126572 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |